COLOMA JASON V (Chief Executive Officer) sold 11.9% of their position (34.50K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $922.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 8/5/2026ACC: 0001676170-26-000016
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-34.50K
Net shares
Net seller
$922.3K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
34.50K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−2.44K
Price / share
$26.71
Trade value
$65.16K
% of position
10.5%
8/3/2026
23.34K→20.90K
Common Stock
Indirect
Shares
−154.00
Price / share
$27.09
Trade value
$4.17K
% of position
0.7%
8/3/2026
20.90K→20.74K
Common Stock
Indirect
Shares
−30.30K
Price / share
$26.71
Trade value
$809.54K
% of position
10.6%
8/3/2026
287.17K→256.87K
Common Stock
Indirect
Shares
−1.60K
Price / share
$27.09
Trade value
$43.44K
% of position
0.6%
8/3/2026
256.87K→255.26K
Total
Net shares
−34.50K
Net value
-$922.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/3/2026 | S · Sale | −2.44K | $26.71 | $65.16K | 10.5% | 23.34K | 20.90K |
| Common Stock Indirect | 8/3/2026 | S · Sale | −154.00 | $27.09 | $4.17K | 0.7% | 20.90K | 20.74K |
| Common Stock Indirect | 8/3/2026 | S · Sale | −30.30K | $26.71 | $809.54K | 10.6% | 287.17K | 256.87K |
| Common Stock Indirect | 8/3/2026 | S · Sale | −1.60K | $27.09 | $43.44K | 0.6% | 256.87K | 255.26K |
| Total | −34.50K | -$922.32K | ||||||
Derivative Transactions0
No derivative transactions reported